Paper16633340
PTEN maintains haematopoietic stem cells and acts in lineage choice and leukaemia prevention.
Zhang J and 11 others. Nature, 2006. Cited by 664 papers, by iCite.
Cite this record
ConductScience Library. PTEN maintains haematopoietic stem cells and acts in lineage choice and leukaemia prevention. Papers, record 16633340. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/16633340
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- PTEN maintains haematopoietic stem cells and acts in lineage choice and leukaemia prevention.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cell Lineage | Major topic |
| Hematopoietic Stem Cells | Major topic |
| Leukemia | Major topic |
| PTEN Phosphohydrolase | Major topic |
| Animals | |
| Cell Count | |
| Cell Cycle | |
| Cell Proliferation | |
| Cyclin D1 | |
| Gene Expression | |
| Mice | |
| Mutation |
Source PubMed
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 16724049 | Stem cells: good, bad and reformable. | https://conductscience.org/library/papers/16724049 |
Source PubMed
Cited by451
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 664 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42982998 | Targeting Quiescent Leukemic Stem Cells to Eliminate Minimal Residual Disease and Prevent Relapse in Hematological Malignancies. | Curr Oncol Rep | 2026 | https://conductscience.org/library/papers/42982998 | PubMed |
| 42806054 | Exploiting an epigenetic resistance mechanism to PI3-kinase inhibition in leukemic stem cells. | Leukemia | 2026 | https://conductscience.org/library/papers/42806054 | PubMed |
| 42238959 | A sustained-release depot formulation of β-nicotinamide mononucleotide for alleviating chemotherapy-induced myelosuppression. | Mater Today Bio | 2026 | https://conductscience.org/library/papers/42238959 | PubMed |
| 42165225 | G0 or no-G0: phosphatase control of quiescence and cell cycle entry. | Biochem Soc Trans | 2026 | https://conductscience.org/library/papers/42165225 | PubMed |
| 40954504 | Ap1s1 reduction in the aging brain heightens neuronal vulnerability to amyloid-β and oxidative stress in Alzheimer's pathogenesis. | Alzheimers Res Ther | 2025 | https://conductscience.org/library/papers/40954504 | PubMed |
| 40755759 | Hes1 in malignant tumors: from molecular mechanism to therapeutic potential. | Front Immunol | 2025 | https://conductscience.org/library/papers/40755759 | PubMed |
| 40700577 | CD99 promotes self-renewal in hematopoietic stem cells and leukemia stem cells by regulating protein synthesis. | Blood | 2025 | https://conductscience.org/library/papers/40700577 | PubMed |
| 40272656 | Modeling of cancer stem cells and the tumor microenvironment Via NT2/D1 cells to probe pathology and treatment for cancer and beyond. | Discov Oncol | 2025 | https://conductscience.org/library/papers/40272656 | PubMed |
| 40258184 | Coordinated regulation of self-renewal and cell cycle during human lympho-myeloid lineage restriction. | Blood | 2025 | https://conductscience.org/library/papers/40258184 | PubMed |
| 39390838 | Anticancer Drug Discovery from Natural Compounds Targeting PI3K/AKT/mTOR Signaling Pathway. | Curr Med Chem | 2025 | https://conductscience.org/library/papers/39390838 | PubMed |
| 39256862 | Macrophage extracellular vesicle-packaged miR-23a-3p impairs maintenance and angiogenic capacity of human endothelial progenitor cells in neonatal hyperoxia-induced lung injury. | Stem Cell Res Ther | 2024 | https://conductscience.org/library/papers/39256862 | PubMed |
| 39025986 | Nudt15-mediated inflammatory signaling contributes to divergent outcomes in leukemogenesis and hematopoiesis. | Leukemia | 2024 | https://conductscience.org/library/papers/39025986 | PubMed |
| 38977676 | tRNA m1A modification regulate HSC maintenance and self-renewal via mTORC1 signaling. | Nat Commun | 2024 | https://conductscience.org/library/papers/38977676 | PubMed |
| 38627382 | Therapeutic role of PTEN in tissue regeneration for management of neurological disorders: stem cell behaviors to an in-depth review. | Cell Death Dis | 2024 | https://conductscience.org/library/papers/38627382 | PubMed |
| 38228958 | Metabolism in Hematopoiesis and Its Malignancy. | Adv Exp Med Biol | 2023 | https://conductscience.org/library/papers/38228958 | PubMed |
| 37931173 | Selective Inhibition of mTORC1 Signaling Supports the Development and Maintenance of Pluripotency. | Stem Cells | 2024 | https://conductscience.org/library/papers/37931173 | PubMed |
| 37665633 | PRL2 inhibition elevates PTEN protein and ameliorates progression of acute myeloid leukemia. | JCI Insight | 2023 | https://conductscience.org/library/papers/37665633 | PubMed |
| 37488179 | Loss of Nudt15 thiopurine detoxification increases direct DNA damage in hematopoietic stem cells. | Sci Rep | 2023 | https://conductscience.org/library/papers/37488179 | PubMed |
| 37274024 | SETD4 Confers Cancer Stem Cell Chemoresistance in Nonsmall Cell Lung Cancer Patients via the Epigenetic Regulation of Cellular Quiescence. | Stem Cells Int | 2023 | https://conductscience.org/library/papers/37274024 | PubMed |
| 37228652 | Regulation of hematopoietic stem cells differentiation, self-renewal, and quiescence through the mTOR signaling pathway. | Front Cell Dev Biol | 2023 | https://conductscience.org/library/papers/37228652 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| CCND1 | 595 | PubTator's text mining | https://conductscience.org/library/genes/595 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/16633340
GET https://conductscience.org/api/papers/v1/16633340/cited_by?page=2